Chromosome Transplantation: Opportunities and Limitations
- PMID: 38667281
- PMCID: PMC11048979
- DOI: 10.3390/cells13080666
Chromosome Transplantation: Opportunities and Limitations
Abstract
There are thousands of rare genetic diseases that could be treated with classical gene therapy strategies such as the addition of the defective gene via viral or non-viral delivery or by direct gene editing. However, several genetic defects are too complex for these approaches. These "genomic mutations" include aneuploidies, intra and inter chromosomal rearrangements, large deletions, or inversion and copy number variations. Chromosome transplantation (CT) refers to the precise substitution of an endogenous chromosome with an exogenous one. By the addition of an exogenous chromosome and the concomitant elimination of the endogenous one, every genetic defect, irrespective of its nature, could be resolved. In the current review, we analyze the state of the art of this technique and discuss its possible application to human pathology. CT might not be limited to the treatment of human diseases. By working on sex chromosomes, we showed that female cells can be obtained from male cells, since chromosome-transplanted cells can lose either sex chromosome, giving rise to 46,XY or 46,XX diploid cells, a modification that could be exploited to obtain female gametes from male cells. Moreover, CT could be used in veterinary biology, since entire chromosomes containing an advantageous locus could be transferred to animals of zootechnical interest without altering their specific genetic background and the need for long and complex interbreeding. CT could also be useful to rescue extinct species if only male cells were available. Finally, the generation of "synthetic" cells could be achieved by repeated CT into a recipient cell. CT is an additional tool for genetic modification of mammalian cells.
Keywords: Duchenne muscular dystrophy; X chromosome; chromosome transplantation; genomic disease; iPSC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells.Stem Cells. 2019 Jul;37(7):876-887. doi: 10.1002/stem.3006. Epub 2019 Apr 2. Stem Cells. 2019. PMID: 30895693
-
Chromosome Transplantation: A Possible Approach to Treat Human X-linked Disorders.Mol Ther Methods Clin Dev. 2020 Jan 21;17:369-377. doi: 10.1016/j.omtm.2020.01.003. eCollection 2020 Jun 12. Mol Ther Methods Clin Dev. 2020. PMID: 32099849 Free PMC article.
-
Olfactory receptor-gene clusters, genomic-inversion polymorphisms, and common chromosome rearrangements.Am J Hum Genet. 2001 Apr;68(4):874-83. doi: 10.1086/319506. Epub 2001 Feb 26. Am J Hum Genet. 2001. PMID: 11231899 Free PMC article.
-
Human artificial chromosomes for pluripotent stem cell-based tissue replacement therapy.Exp Cell Res. 2020 Apr 1;389(1):111882. doi: 10.1016/j.yexcr.2020.111882. Epub 2020 Feb 1. Exp Cell Res. 2020. PMID: 32017931 Review.
-
Mammalian Synthetic Biology: Time for Big MACs.ACS Synth Biol. 2016 Oct 21;5(10):1040-1049. doi: 10.1021/acssynbio.6b00074. Epub 2016 Apr 20. ACS Synth Biol. 2016. PMID: 27076218 Review.
References
-
- Ferrari S., Valeri E., Conti A., Scala S., Aprile A., Di Micco R., Kajaste-Rudnitski A., Montini E., Ferrari G., Aiuti A., et al. Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy. Cell Stem Cell. 2024;30:549–570. doi: 10.1016/j.stem.2023.04.014. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical